Derivatization and determination of residual N,N-Carbonyldiimidazole by LC for an in-process control test.

J Pharm Biomed Anal

Chemical Process Development, Bristol Myers Squibb, 1 Squibb Dr., New Brunswick, NJ 08903, USA. Electronic address:

Published: January 2022

For the robust analysis of N,N-Carbonyldiimidazole (CDI), its derivatization into a more stable compound may be needed. Herein, the reaction of CDI with N-benzylmethylamine followed by LC-UV quantitative analysis was explored. Reaction conditions as well as LC method feasibility were demonstrated by qualification of selectivity from other impurities and reagents, linearity across a range of 0.05-0.15%w/w, spike and recovery across a range of 0.05-0.15%w/w, reaction reproducibility with various samples, reagents and analytical chemists, and sample stability of over 24 h. Rapid and quantitative derivatization of residual CDI was achieved at 0.1% w/w relative to the synthetic product under consideration. A fit-for-purpose limit test using a RPLC-UV method as an in-process control for the reaction completion of product, at scale, was successfully implemented and executed.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jpba.2021.114395DOI Listing

Publication Analysis

Top Keywords

in-process control
8
range 005-015%w/w
8
derivatization determination
4
determination residual
4
residual nn-carbonyldiimidazole
4
nn-carbonyldiimidazole in-process
4
control test
4
test robust
4
robust analysis
4
analysis nn-carbonyldiimidazole
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!